Phenylketonuria Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028
Global Phenylketonuria Treatment Market: Overview
The global phenylketonuria treatment market has witnessed a steadfast growth, owing to the rising number of people suffering from phenylketonuria (PKU) disorder. Although, it is a rare type of genetic disorder, which mainly increases the phenylalanine level in the blood, resulting problems throughout the victims’ bodies. The major problems associated with this phenylketonuria disorder include developmental delays, seizures, and behavioural or mental health problems. The predominant reason involved behind PKU is the deficiency of an enzyme, commonly known as Phenylalanine hydroxylase (PAH). This enzyme’s prime role is to convert phenylalanine to tyrosine. However, PKU is also caused by the defect in PAH’s co-factor, especially BH4.
From the perspective of products, the global phenylketonuria treatment market is bifurcated into nutrition supplements and drugs. Among these two, the nutrition supplements segment showcases a significant share in the global phenylketonuria treatment market, on account of being extensively prescribed by physicians coupled with a huge requirement of specialized diet at the time of the phenylketonuria treatment. The report thoroughly explains the segments, key drivers, opportunities, and competitive landscape of the global phenylketonuria treatment market. Moreover, the report could be true guideline for the major stakeholders in the global phenylketonuria treatment market.
Global Phenylketonuria Treatment Market: Notable Developments
Some of the developments which help in contouring the shape of the global phenylketonuria treatment market in a big way include:
Key players operating in the global phenylketonuria treatment market include Dimension Therapeutics Inc., Synthetic Biologics., SOM Innovation Biotech SL., and Erytech Pharma.
Global Phenylketonuria Treatment Market: Key Growth Drivers
A few factors triggering the growth of the global phenylketonuria treatment market in a positive way include:
Growing Research and Development of Novel Drugs to Boost Market
A few medications which respond positively in treating phenylketonuria include Playnziq, Kuvan, and gene therapy. These drugs help in terminating the symptoms of phenylketonuria and reduce the possibility of brain damage. Such factors positively influencing the growth of the global phenylketonuria treatment market. Phenylketonuria refers as an inherited genetic condition, predominantly caused due to a major defect in PAH gene. Elevated levels of phenylalanine in the blood cam occur, on account of the high intake of proteins such as meats and egg.
However, for a new-born to inherit phenylketonuria, both parents should pass on a defective PAH gene. If a timely treatment of phenylketonuria cannot take place for an infant, he/she may develop symptoms such as tremors, seizures, stunted growth, shaking, and hyperactivity. Therefore, soaring g demand for several effective treatments for phenylketonuria is further complementing to the growth of the global phenylketonuria treatment market.
Rising Awareness about Timely Treatment of Phenylketonuria Fillips Market
Growing prevalence of phenylketonuria across the globe acts as a major key driver in the global phenylketonuria treatment market. Numerous screening tests which are widely used for the diagnosis of phenylketonuria include immunoassay, bacterial inhibition assay, and mass spectroscopy analysis for amino acid. All these tests play an integral part in the treatment of phenylketonuria disorder, which in turn is also propelling expansion in the global phenylketonuria treatment market.
Furthermore, several other factors such as intensive research in the genomics field and increasing awareness regarding the timely treatment of phenylketonuria are responsible for triggering the growth of the global phenylketonuria treatment market. Besides this, rapid advancements in the global healthcare industry and rapidly changing lifestyle are also providing major growth impetus to the global phenylketonuria treatment market.
Global Phenylketonuria Treatment Market: Regional Outlook
On the regional front, North America is dominating over other regions in the global phenylketonuria treatment market, on account of the increasing number of advanced screening procedures. Along with this, burgeoning population suffering from phenylketonuria disorder and rapid technological advancements in the healthcare industry are also responsible for fueling growth in the phenylketonuria treatment in this region.
The study presents reliable qualitative and quantitative insights into:
The regional analysis covers:
The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.
Highlights of the report:
Note: Immense care has been taken to present data with the highest levels of accuracy in all TMRResearch reports. Nevertheless, recent developments related to market/vendor landscape may take time to reflect in the analysis.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report